Beth Canova is a veteran of the publishing industry, specializing in cryptocurrency-related information and guidance. As the ...

The volatility you feel isn’t where you think it is. With the 10-year Treasury yield near a 24-year high, here’s what held up ...

The opening bell tells you nothing. Here's what actually predicts a winning IPO.

Martin D. Weiss, Ph.D. Dr. Weiss is the founder of Weiss Ratings, the nation’s leading provider of 100% independent grades on stocks, mutual funds and financial institutions, as well as the world’s ...

October may be known for black swan events — The Bank Panic of 1907, Black Tuesday in 1929, Black Monday in 1987 and the ...

From his unique vantage point at the center of the U.S. tech industry, Michael A. Robinson has a record of making big calls ...

Sure enough, Bitcoin made a significant low on Feb. 5 at about $60,000. That was within ~$2,000 of BTC’s bear market low at ...

Here's my pick to play the tokenization narrative. When econometrician and pro trader Juan M. Villaverde first applied his algorithms to Bitcoin, he discovered a regular cyclical pattern. He has since ...

The company could crash the markets, and that might be the best-case scenario ...

So it’s no surprise that he became the mastermind behind the data that powers Day One Syndicate. He knows our model like the ...

Sean Brodrick tracks the fast-rising world of precious metals and critical minerals that are reshaping global supply chains.

SMMT fell 5.51% to $16.96 from $17.95 the previous trading day Weiss Ratings assigns D- (Sell) Market cap is $13.81B Summit Therapeutics Inc. (SMMT) is under pressure on Thursday, last trading ...